Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Coto Laurel, Ponce, Puerto Rico

Updated:

A
1. In the area of Medicine they have staff working twelve hours uninterrupted in Covid area. These in turn use the same gown to treat Covid-19 positive patients as those who are suspected of contagion and are in isolation. The staff is not undergoing proper molecular testing. … See More
Staff who have had contact with people with positive diagnosis and who have responsibly let the hospital administration know are not removed from their work area, in a preventive manner, nor are they carried out proper tests. 4. There are one to two employees with Covid-19 positive diagnosis per department. Protective equipment is being limited to staff in the Emergency Room.

Alleged Hazards: 5, Employees Exposed: 30
Source: Osha.gov | Receip Date: 2020-11-24
See Less

#coronaviruscovid19 #osha #highway506 #cotolaurel #ponce #puertorico

A
In the facilities of Walmart in Ponce Town there is no control of the people at the entrance and inside there are hundreds of people without social distancing

Allied Hazards: 1, Employees Exposed: 300
Source: Osha.gov | Receipt Date: 2020-08-17

#coronaviruscovid19 #osha #walmart #333puertorico14 #cotolaurel #ponce #puertorico

Recent Interesting Reports

T
I don't know what happened, All I know is I received an email from my credit union last week asking me if I ordered anything online, and I told them no, and then this week I get this package. The bubble envelope says Fullfillment House PO Box 5708 Tampa FL 33675

#unorderedpackage #delivery #uspostalservice #tampa #florida #us

AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found during stability testing at a 3rd party lab. Atovaquone Oral Suspension, USP was distributed between 03/18/2024 through 03/21/2024 … See More
Nationwide to Wholesalers. To date, AvKARE has not received any reports of adverse events related to this recall.

Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.

Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.

The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.

AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.  

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024

Source: www.fda.gov
See Less

#drugs #us

Last 30 days